Growth Metrics

Biocryst Pharmaceuticals (BCRX) Treasury Shares (2022 - 2026)

Biocryst Pharmaceuticals filings provide 6 years of Treasury Shares readings, the most recent being $11.1 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 19.94% to $11.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.1 million, a 19.94% increase, with the full-year FY2025 number at $11.1 million, up 19.94% from a year prior.
  • Treasury Shares hit $11.1 million in Q4 2025 for Biocryst Pharmaceuticals, up from $999000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $11.1 million in Q4 2025 to a low of $813000.0 in Q1 2024.
  • Median Treasury Shares over the past 4 years was $4.6 million (2022), compared with a mean of $4.8 million.
  • The widest YoY moves for Treasury Shares: up 1018.45% in 2025, down 82.87% in 2025.
  • Biocryst Pharmaceuticals' Treasury Shares stood at $4.2 million in 2022, then plummeted by 78.0% to $915000.0 in 2023, then soared by 915.19% to $9.3 million in 2024, then grew by 19.94% to $11.1 million in 2025.
  • The last three reported values for Treasury Shares were $11.1 million (Q4 2025), $999000.0 (Q3 2025), and $882000.0 (Q2 2025) per Business Quant data.